Upregulation of Toll‑like receptor 2 expression in colorectal cancer infected by human cytomegalovirus

Li,Xutong; Qian,Dongmeng; Ju,Fang; Wang,Bin

doi:10.3892/ol.2014.2621

January-2015 Volume 9 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

January-2015 Volume 9 Issue 1

Full Size Image

Article

Upregulation of Toll‑like receptor 2 expression in colorectal cancer infected by human cytomegalovirus

Authors:
- Xutong Li
- Dongmeng Qian
- Fang Ju
- Bin Wang
View Affiliations / Copyright

Affiliations: Department of Microbiology, Medical College, Qingdao University, Qingdao, Shandong 266071, P.R. China, Department of Oncology, Second Affiliated Hospital, Medical College, Qingdao University, Qingdao, Shandong 266042, P.R. China
Pages: 365-370
|
Published online on: October 15, 2014

https://doi.org/10.3892/ol.2014.2621
Expand metrics +

Abstract

The aim of the present study was to investigate the association between Toll‑like receptor 2 (TLR2) expression and human cytomegalovirus (HCMV) in colorectal carcinoma by detecting the expression of IE1‑72, TLR2, TLR4 and tumor necrosis factor (TNF)‑α in colorectal carcinoma and colon adenoma samples, as well as by analyzing the mRNA levels of the proteins in colon cancer cell lines, following HCMV infection. For this study, 56 colorectal cancer and 36 colon adenoma samples were collected, and normal mucosal tissue adjacent to the tumor was used as the control. The expression of the IE1‑72, TLR2, TLR4, nuclear factor (NF)‑κB and TNF‑α protein was detected by immunohistochemistry. Cells from the SW480 human colon carcinoma cell line were infected with HCMV. The expression of IE1‑72, TLR2, TLR4, NF‑κB and TNF‑α mRNA was quantified at different time points prior to and following infection. The positive expression rate of IE1‑72 was 44.6% (25/56) in colorectal cancer and 41.7% (15/36) in colon adenoma. These rates were significantly higher when compared with the 12.5% (7/56) observed in the normal tissues adjacent to the cancer tissues (P<0.05). The expression levels of TLR2, TLR4, NF‑κB and TNF‑α in colorectal cancer and adenoma were also higher than those in the control tissues. Furthermore, the expression of IE1‑72 in colorectal cancer tissues was found to correlate with TLR2 and TLR4, and the correlation coefficients were 0.515 and 0.462, respectively. Following the infection of SW480 cells, the mRNA levels of TLR2 and TNF‑α increased gradually from 6 h, peaked at 48 h, and then decreased gradually. No significant differences in TLR4 and NF‑κB expression were identified. The results of the present study indicated that there is a specific association between HCMV and the occurrence and development of colorectal cancer, which may be facilitated by the TLR2 signaling pathway.

View Figures

View References

1	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
2	JH, PZ and WQC: 2012, China cancer registration report. Military medical press; pp. 15–16. 2013
3	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
4	Hussain SP and Harris CC: Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
5	Kuper H, Adami HO and Trichopoulos D: Infections as a major preventablecause of human cancer. J Intern Med. 248:171–183. 2000. View Article : Google Scholar : PubMed/NCBI
6	Fidler IJ: Modulation of the organ microenvironment for treatment of cancer metastasis. J Natl Cancer Inst. 87:1588–1592. 1995. View Article : Google Scholar : PubMed/NCBI
7	Soroceanu L and Cobbs CS: Is HCMV a tumor promoter? Virus Res. 157:193–203. 2011. View Article : Google Scholar :
8	Harkins L, Volk AL, Samanta M, et al: Specific localization of human cytomegalovirus nucleic acids and proteins in human colorectal tumor. Lancet. 360:1557–1563. 2002. View Article : Google Scholar : PubMed/NCBI
9	Chen HP, Jiang JK, Chen CY, et al: Human cytomegalovirus preferentially infects the neoplastic epithelium of colorectal cancer: a quantitative and histological analysis. J Clin Virol. 54:240–244. 2012. View Article : Google Scholar : PubMed/NCBI
10	Akintola-Ogunremi O, Luo Q, He TC and Wang HL: Is cytomegalovirus associated with human colorectal tumorigenesis? Am J Clin Pathol. 123:244–249. 2005. View Article : Google Scholar : PubMed/NCBI
11	Knösel T, Schewe C, Dietel M and Petersen I: Cytomegalovirus is not associated with progression and metastasis of colorectal cancer. Cancer Lett. 211:243–247. 2004. View Article : Google Scholar : PubMed/NCBI
12	Bender C, Zipeto D, Bidoia C, et al: Analysis of colorectal cancers for human cytomegalovirus presence. Infect Agent Cancer. 4:62009. View Article : Google Scholar : PubMed/NCBI
13	Compton T, Kurt-Jones EA, Boehme KW, et al: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol. 77:4588–4596. 2003. View Article : Google Scholar : PubMed/NCBI
14	Kawasaki H, Altieri DC, Lu CD, et al: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:5071–5074. 1998.PubMed/NCBI
15	Harkins L, Volk AL, Samanta M, et al: Specific localization of human cytomegalovirus nucleic acids and proteins in human colorectal tumor. Lancet. 360:31557–1563. 2002. View Article : Google Scholar
16	Cobbs CS, Harkins L, Samanta G, et al: Human cytomegalovirus infection and expression in human malignant glioma1. Cancer Res. 62:3347–3350. 2002.PubMed/NCBI
17	Samanta M, HarIim L, Klemm K, et al: High prevalence of humancytomegalovims in prostatic intraepithelial neoplasm and prostatic carcinoma. J Urol. 170:998–1002. 2003. View Article : Google Scholar : PubMed/NCBI
18	Barami K: Oncomodulatory mechanisms of human cytomegalovirus in gliomas. J Clin Neurosci. 17:819–823. 2010. View Article : Google Scholar : PubMed/NCBI
19	Maussang D, Verzijl D, van Walsum M, et al: Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA. 103:13068–13073. 2006. View Article : Google Scholar : PubMed/NCBI
20	Cobbs CS, Sorocean UL, Denham S, et al: Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1mediated mitogenicity. Cancer Res. 68:724–730. 2008. View Article : Google Scholar : PubMed/NCBI
21	Cobbs CS, Soroceanu L, Denham S, et al: Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness. J Neurooncol. 85:271–280. 2007. View Article : Google Scholar : PubMed/NCBI
22	Cinatl J Jr, Scholz M and Doerr HW: Role of tumor cell immune escapemechanis ms in cytomegalovirus-mediated oncomodulation. Med Res Rev. 25:167–185. 2005. View Article : Google Scholar
23	Lopper M and Compton T: Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion. J Virol. 78:8333–8341. 2004. View Article : Google Scholar : PubMed/NCBI
24	Thompson JM and Iwasaki A: Toll-like receptors regulation of viral infection and disease. Adv Drug Deliv Rev. 60:786–794. 2008. View Article : Google Scholar : PubMed/NCBI
25	Tsan MF: Toll-like receptors, inflammation and cancer. Semin Cancer Biol. 16:32–37. 2006. View Article : Google Scholar
26	Boehme KW, Guerrero M and Compton T: Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J Immunol. 177:7094–7102. 2006. View Article : Google Scholar : PubMed/NCBI
27	Juckem LK, Boehme KW, Feire AL and Compton T: Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J Immunol. 180:4965–4977. 2008. View Article : Google Scholar : PubMed/NCBI
28	Rosen EM, Goldberg ID, Liu D, et al: Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res. 51:5315–5321. 1991.PubMed/NCBI
29	Arnott CH, Scott KA, Moore RJ, et al: Expression of both TNFalpha receptor subtypes is essential for optimal skin tumour development. Oncogene. 23:1902–1910. 2004. View Article : Google Scholar
30	Karin M: Nuclear factor-κB in cancer development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
31	Ghosh S and Karin M: Missing pieces in the NF-κB puzzle. Cell Suppl. 109:S81–S96. 2002.